Heterozygous mutations in the human paired box gene PAX6 lead to impaired glucose tolerance. Although embryonic deletion of the Pax6 gene in mice leads to loss of most pancreatic islet cell types, the functional consequences of Pax6 loss in adults are poorly defined. Here we developed a mouse line in which Pax6 was selectively inactivated in ␤ cells by crossing animals with floxed Pax6 alleles to mice expressing the inducible Pdx1CreERT transgene. Pax6 deficiency, achieved by tamoxifen injection, caused progressive hyperglycemia. Although ␤ cell mass was preserved 8 days post-injection, total insulin content and insulin:chromogranin A immunoreactivity were reduced by ϳ60%, and glucose-stimulated insulin secretion was eliminated. RNA sequencing and quantitative real-time PCR analyses revealed that, although the expression of key ␤ cell genes, including Ins2, Slc30a8, MafA, Slc2a2, G6pc2, and Glp1r, was reduced after Pax6 deletion, that of several genes that are usually selectively repressed ("disallowed") in ␤ cells, including Slc16a1, was increased. Assessed in intact islets, glucose-induced ATP:ADP increases were significantly reduced (p < 0.05) in ␤Pax6KO versus control ␤ cells, and the former displayed attenuated increases in cytosolic Ca 2؉ . Unexpectedly, glucoseinduced increases in intercellular connectivity were enhanced after Pax6 deletion, consistent with increases in the expression of the glucose sensor glucokinase, but decreases in that of two transcription factors usually expressed in fully differentiated ␤-cells, Pdx1 and Nkx6.1, were observed in islet "hub" cells. These results indicate that Pax6 is required for the functional identity of adult ␤ cells. Furthermore, deficiencies in ␤ cell glu-cose sensing are likely to contribute to defective insulin secretion in human carriers of PAX6 mutations.
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Defective insulin secretion underlies all forms of diabetes mellitus, a disease that now affects more than 422 million individuals worldwide (World Health Organization). Insulin is stored and released from ␤ cells within pancreatic islets of Langerhans following elevations in glucose concentration (1) . In response to high glucose, enhanced flux through glycolysis and mitochondrial oxidative metabolism (2) leads to increases in cytosolic ATP/ADP concentrations, the closure of ATP-sensitive K ϩ (K ATP ) channels (3), cellular depolarization, and Ca 2ϩ influx (4) . Ca 2ϩ sensors on secretory granules then catalyze hormone release through exocytosis (5) . In the context of the intact islet, ␤ cell-␤ cell connections (6, 7) then create a coordinated network ensuring the optimal regulation of secretion through propagation of Ca 2ϩ and other signals (8) .
Paired box 6 (PAX6) is a transcription factor crucial for the development of the eye, brain, olfactory system, and endocrine pancreas. Heterozygous mutations in the PAX6 gene, which result in the production of a truncated, non-functional protein (9) , cause abnormal iris formation (aniridia) and impaired glucose tolerance (10) . Correspondingly, PAX6 binding domains are found in the promoter regions of several key ␤ cell genes (11) , and islets derived from a human pedigree harboring an inactivating missense PAX6 mutation are deficient in proinsulin processing enzymes (PCSK1/3) (12) . Interestingly, we observed no changes in Pcsk1 expression in this study, arguing that the alterations observed in man may reflect an indirect action of PAX6. Furthermore, inheritance of the G allele at the single nucleotide polymorphism rs685428 lowers PAX6 expression in man and is associated with increased fasting insulin and lower proinsulin:insulin ratio (13) .
In mice, homozygocity for the "small eye" Pax6 mutant allele (Sey Neu ) leads to death at perinatal stages, and affected animals have dramatically reduced numbers of all islet cell types (14) . Although deletion throughout the pancreas leads to overt diabetes and loss of ␤ cells (15) , heterozygous loss-of-function mutants show age-dependent (12) and diet-dependent (16) impairments in glucose tolerance. Finally, Pax6 expression is decreased in a rat model of T2D (the Zucker diabetic fatty rat) (17) .
Recent studies have also indicted that PAX6 may be important in maintaining the differentiated state and identity of the adult ␤ cell. Thus, conditional inactivation of Pax6 at post-natal stages in mice with a tamoxifen-inducible ubiquitous Cre leads to the development of a severe diabetic phenotype (18) . Pancreatic analysis revealed a reduction in the expression of the insulin 1 and insulin 2, glucagon, and somatostatin genes, coupled with increases in the number of ghrelin-positive cells (18) . The latter were also increased when deletion was restricted to either ␣ or ␤ cells in adult mice (19) .
By contrast, few studies have examined how Pax6 deletion affects the functional maturity of the adult ␤ cell. One report (20) , based on RNA interference, provided evidence that Pax6 is required in the adult rat ␤ cell for normal insulin secretion and the expression of key genes, including Ins1 and Ins2. However, the above approach was complicated by the requirement for ␤ cell isolation prior to gene silencing and by potential offtarget effects of silencing RNAs. Further, glucose sensing was examined in the latter study using isolated ␤ cells rather than the intact islet, where responses to stimulation can differ markedly, and the gain of function resulting from intercellular interactions across the islet syncytium is lost (21) . On the other hand, studies on the effect of Pax6 deletion using Cre-mediated recombination in the adult have used either a ubiquitous Cre (18) or Cre expression driven by the rat insulin 2 promoter (RIP), which also leads to substantial recombination in the brain (22) .
The aims of the present work were therefore to achieve efficient Pax6 deletion selectively in the adult mouse ␤ cell using targeted recombination at floxed alleles with an alternative tamoxifen-inducible Cre system (Pdx1CreERT) (23, 24) , to examine ␤ cell function and glucose-sensing in vivo and in vitro after Pax6 ablation, and to determine the role of PAX6 in the control of a broader range of genes than what has been examined previously, including those that are normally selectively silenced, or "disallowed," in mature ␤ cells (25, 26) . Alongside decreases in the expression of ␤ cell signature genes, up-regulation of the latter, which occurs in type 2 diabetes (27, 28) , is likely to report a loss of normal cellular identity.
We show that Pax6 deletion achieved in this way leads to profound diabetes, consistent with earlier findings using alternative Cre drivers. Critically, we demonstrate marked abnormalities in gene expression, glucose metabolism, Ca 2ϩ dynamics, and insulin secretion in ␤Pax6KO mouse islets early in the development of diabetes, which are likely to play an important part in ␤ cell secretory failure. Unexpectedly, islets null for Pax6 in the ␤ cell display normal or enhanced cellular interconnectivity. Thus a functionally interconnected ␤ cell network can be maintained despite the partial loss of full ␤ cell identity.
Results

Efficient and inducible deletion of Pax6 from the adult mouse ␤ cell
Mice harboring LoxP sites surrounding exons 5, 5a, and 6 of Pax6 were crossed to Pdx1CreER mice. The breeding strategy used resulted in all animals carrying two copies of the floxed Pax6 gene, but only half of these animals possessed a Cre allele (Cre ϩ ; Pax6 fl/fl ::Pdx1CreERT ϩ/Ϫ ; ␤Pax6KO). Tamoxifen is expected to result in gene deletion only in animals that possess the Cre transgene ( Fig. 1A) .
Eight week-old Pax6 fl/fl ::Pdx1CreERT ϩ/Ϫ and control Pax6 fl/fl :: Pdx1CreERT Ϫ/Ϫ littermates were injected daily with tamoxifen (2 mg) for 5 days. Islets isolated 2 weeks after the final tamoxifen injection showed substantially (ϳ70%) reduced levels of Pax6 mRNA compared with littermate controls (Fig. 1B, 1 .00 Ϯ 0.00 versus 0.35 Ϯ 0.16 for Cre Ϫ versus Cre ϩ , -fold change versus Cre Ϫ , p Ͻ 0.01), consistent with deletion from the majority of the islet ␤ cell compartment (ϳ60% of all cells) (29) . A comparable reduction in PAX6 immunoreactivity was also observed by Western blotting (Fig. 1C ).
Immunocytochemical analysis of pancreatic slices for PAX6, insulin, and glucagon assessed 8 days after the first tamoxifen injection ( Fig. 1D ) revealed an ϳ80% decrease in PAX6 staining across all islet cells ( Fig. 1 , D and E) with essentially complete (Ͼ98%) elimination of PAX6 immunoreactivity from ␤-cells and a more minor reduction (ϳ25%) in ␣ cells ( Fig. 1 , D and F), presumably reflecting maintained expression of Pdx1 in a minority of ␣ cells, some of which may also express other islet hormones (30) . We note that this Cre deleter strain does not catalyze significant recombination in the hypothalamus (31) .
Despite a dramatic decrease in insulin immunoreactivity on a per-cell basis ( Fig. 1D , g versus c), immunocytochemical analysis ( Fig. 1G ), assessed at the same time point, revealed no significant changes in total ␤ cell mass ( Fig. 1G , 0.23 Ϯ 0.05% versus control 0.17 Ϯ 0.02%, ns, 4 Student's t test, n ϭ 4 animals/ genotype), ␣ cell mass ( Fig. 1H , 0.069 Ϯ 0.019% versus control 0.031 Ϯ 0.004%, ns, Student's t test, n ϭ 4) or ␤ to ␣ cell ratio ( Fig. 1I, 4 .3 Ϯ 1.5 versus control 5.5 Ϯ 0.9, ns, Student's t test, n ϭ 4).
Deletion of Pax6 impairs glucose homeostasis in vivo
␤Pax6 KO mice showed increased blood glucose levels from 8 days after final tamoxifen injection ( Fig. 2A, 9 .45 Ϯ 0.35 mM versus 26.15 Ϯ 1.13 mM for Cre Ϫ versus Cre ϩ , respectively). This change was further exacerbated over time, with ␤Pax6KO animals showing an average glycemia of 50.0 mM at the time of termination. Consistent with overt diabetes, the body weight of ␤Pax6KO mice began to decline 7 days after the final tamoxifen injection (Fig. 2B ). Two weeks after tamoxifen treatment, the decline in body weight was so severe that ␤Pax6KO mice were terminated in accordance with United Kingdom Home Office guidelines. We note that expression of the Pdx1CreERT transgene alone is not expected to impact insulin secretion or glucose tolerance (32) . Correspondingly, Pax6 fl/fl ::Pdx1CreERT ϩ/Ϫ mice remained normoglycemic in the absence of tamoxifen administration (data not shown). Likewise, tamoxifen alone, at the doses used here, exerts no effect on glycemia in wild-type C57BL/6J mice (31) . Hence, any metabolic changes observed can reasonably be ascribed to the deletion of Pax6.
Insulin sensitivity, as assessed by intraperitoneal insulin tolerance test, was not markedly affected by Pax6 deletion in ␤ cells despite increased blood glucose levels ( Fig. 2C ). However, upon termination 2 weeks after tamoxifen treatment, blood glucose levels were significantly higher in ␤Pax6KO animals than in littermate controls ( Fig. 2D, 9 .10 Ϯ 0.14 mM versus 47.2 Ϯ 0.04 mM for Cre Ϫ versus Cre ϩ , p Ͻ 0.001). This change was accompanied by significantly decreased plasma insulin levels ( Fig. 2E, 1 .51 Ϯ 0.15 ng/ml versus 0.83 Ϯ 0.16 ng/ml for Cre Ϫ versus Cre ϩ , p Ͻ 0.05), suggesting that the observed hyperglycemia, caused by Pax6 deletion, is likely to be due to insufficient insulin output from pancreatic ␤ cells.
Total insulin levels, as measured in islets isolated from animals 1 week after tamoxifen treatment, were significantly reduced by Pax6 deletion (Fig. 2F; 14 .5 Ϯ 2.97 ng/ml/islet versus 6.28 Ϯ 1.57 ng/ml/islet for Cre Ϫ versus Cre ϩ , respectively; p Ͻ 0.05). A similar reduction, to levels observed after incubation at 3 mM glucose, was apparent after normalization to islet DNA content (660 Ϯ 63 versus 322 Ϯ 69 ng insulin/ng DNA, p Ͻ 0.05) or to total insulin content (0.41 Ϯ 0.03 versus 0.016 Ϯ 0.03%, p Ͻ 0.01). The latter observation excludes the possibility that our failure to detect an increase in insulin secretion from ␤Pax6KO islets after incubation at 17 versus 3 mM glucose simply reflects the lowered insulin content of KO versus control islets.
Finally, we measured basal and glucose-stimulated insulin secretion from isolated islets ( Fig. 2G ). Release of insulin from ␤Pax6KO islets tended to be lower than that from control islets when measured at 3 mM glucose, but, in contrast to the ϳ4-fold Pax6 controls functional ␤ cell identity stimulation observed in wild-type islets at 17 mM glucose, no further increase was detectable from ␤Pax6KO islets at this higher glucose concentration ( Fig. 2G ). This altered response was not associated with any marked redistribution of granules away from the plasma membrane (i.e. in a reduction in the number of "morphologically docked" granules), as assessed by TIRF microscopy (Fig. 2 , H and I), suggesting that defects later in granule release, or in the generation of metabolic signals required for exocytosis, are defective in this model.
Deletion of Pax6 alters the expression of ␤ cell signature and disallowed genes
Consistent with a loss of ␤ cell identity, the expression of Ins2, Slc30a8, MafA, Slc2a2, and Glp1r, signature genes, which are all highly expressed in healthy ␤ cells and are essential for normal function (1), were all significantly reduced by Pax6 deletion 8 days after tamoxifen treatment, as assessed by qRT-PCR analysis (Fig. 3 , A-E; p Ͻ 0.05 versus Cre-for all genes). In contrast, the expression of the glucose sensor glucokinase (Gck) tended to increase (Fig. 3F , ns versus Cre Ϫ ). Interestingly, the Pax6 controls functional ␤ cell identity expression of the ␤ cell disallowed gene Slc16a1, encoding monocarboxylate transporter 1 (MCT-1), was significantly increased by Pax6 deletion (Fig. 3G , p Ͻ 0.05 versus Cre Ϫ ) at this stage. However, the expression of Ldha, another disallowed gene, was not affected (Fig. 3H , p Ͼ 0.05 versus Cre Ϫ ).
As expected based on earlier models (18, 19) , glucagon expression was not significantly altered by Pax6 deletion from ␤ cells ( Fig. 3J , ns versus Cre Ϫ ). Correspondingly, fasting plasma glucagon levels were also unchanged between control and Pax6 null animals (147 Ϯ 49.6 and 128 Ϯ 28.7 pg/ml in control and ␤Pax6KO mice; n ϭ 4 and 6 animals, respectively; p Ͼ 0.05). In contrast, ghrelin expression was dramatically (Ͼ40-fold) increased ( Fig. 3K , p Ͻ 0.05 versus Cre Ϫ ).
To provide a transcriptome-wide assessment of the impact of Pax6 deletion, we next performed massive parallel RNA sequencing (RNAseq) on islets from control or null animals (supplemental Fig. S1 ). This revealed, first, that disallowed genes were selectively enriched among the up-regulated genes from ␤Pax6KO islets, as assessed by GSEA (supplemental RNAseq also demonstrated that, although markers of ␤ cell progenitors, notably Neurogenin3, were up-regulated in response to the loss of PAX6, transcription factors characteristic of the fully differentiated ␤ cell, including Nkx6.1, Pdx1, and MafA, were repressed in knock-out islets (supplemental Fig.  S1C ). Interestingly, these observations suggest that PAX6 may serve as either an activator or a repressor depending on context and target, as shown recently for the ␤ cell-enriched factors RFX6 (34) and Nkx2.2 (35) .
The above approach also corroborated the changes observed above, including in the expression of ghrelin (increased 32fold), Ins2 (decreased 5.5-fold), and Gck (increased 2.8-fold) after Pax6 deletion. Gcg, Ppy, and SSt expression was barely altered (supplemental Fig. S1D ), and Pcsk1 and Pcsk2 mRNA levels were essentially unchanged (supplemental Fig. S1E ), arguing against alterations in prohormone processing. Affected genes included Ero1lb, a protein disulfide isomerize strongly enriched in ␤ cells and likely involved in insulin maturation (36) , and G6pc2, involved in glucose sensing (37) , each being significantly down-regulated (supplemental Fig. S1E ). Of note, we observed a large (156-fold, p ϭ 1.5 ϫ 10 Ϫ215 ) increase in the expression of the voltage-gated potassium channel Kcnj5, likely to exert significant effects on membrane excitability and thus Ca 2ϩ dynamics (supplemental Fig. S1E ).
␤Pax6KO islet cells lose insulin expression but retain neuroendocrine properties
Previous reports (19) and the above findings indicate that Pax6-null ␤ cells are shunted toward an alternative cell fate. We therefore stained pancreatic slices obtained from animals 8 days after the final tamoxifen injection for the neuroendocrine marker chromogranin A (38) alongside insulin and glucagon ( Fig. 4A ). Expressing the number of total insulin-and glucagonimmunopositive area as a ratio of the total chromogranin Aimmunopositive area revealed that deletion of Pax6 significantly reduced the insulin:chromogranin A ratio ( Fig. 4B; 0 .89 Ϯ 0.02 versus 0.38 Ϯ 0.02 for Cre Ϫ versus Cre ϩ , respectively; p Ͻ 0.001), whereas the glucagon:chromogranin A ratio was not significantly changed ( Fig. 4C, 0 .14 Ϯ 0.04 versus 0.19 Ϯ 0.02 for Cre Ϫ versus Cre ϩ , ns).
Islets isolated from ␤Pax6KO mice show impaired glucoseinduced cytosolic ATP/ADP increases and intracellular Ca 2؉ dynamics
Given the absence of glucose-stimulated insulin secretion and the changes in gene expression and apparent cellular identity observed above, we next determined whether disruption of Pax6 may interfere with glucose metabolism or sensing by ␤ cells within the intact islet. We first used the recombinant cytosol-targeted ATP/ADP probe Perceval (39, 40) and Nipkow spinning disc confocal microscopy (41, 42) . Expression of the above sensor is largely restricted to the ␤ cell (34) because of the apparent tropism of adenoviruses toward this cell type (43) . Exposure to high (11 mM) glucose caused a time-dependent increase in ATP/ADP ratio in control islets as expected (40, 41) , and this increase was reduced in amplitude by ϳ30% in ␤Pax6KO islets (Fig. 5, A and B ; 0.15 Ϯ 0.01 arbitrary units (AU) versus 0.11 Ϯ 0.01 AU for Cre Ϫ versus Cre ϩ , respectively; p Ͻ 0.05; supplemental Movies 1 and 2). Pax6 deletion also markedly reduced the number of glucose-responsive cells, as assessed at 11 mM glucose (Fig. 5 , C and D; 53.9 Ϯ 4.93 versus 25.8 Ϯ 2.30 for Cre Ϫ and Cre ϩ , respectively; p Ͻ 0.001). Similar differences between ␤Pax6null and control islets were also apparent after stimulation at a lower glucose concentration (8 mM; Fig. 5 , E and F; 0.07 Ϯ 0.01 versus 0.02 Ϯ 0.005 AU30 for Cre Ϫ and Cre ϩ , respectively; p Ͻ 0.001).
Because impairments in ATP generation are likely to affect the closure of K ATP channels, impacting plasma membrane depolarization and Ca 2ϩ influx (1), we next sought to determine how intracellular Ca 2ϩ dynamics may be affected by Pax6 deletion. Islets were therefore loaded with the trappable intracellular Ca 2ϩ probe Fluo-2, and confocal imaging was performed essentially as above (albeit at a higher acquisition rate). Pax6 deletion reduced both the amplitude (Fig. 6A; 0 .90 Ϯ 0.13 AU versus 0.33 Ϯ 0.04 AU for Cre Ϫ versus Cre ϩ , respectively; p Ͻ 0.001) and the area under the curve (Fig. 6A, 2819 
Individual ␤ cell Ca 2؉ responses in ␤Pax6KO islets show high levels of coordination
Although average islet Ca 2ϩ responses to glucose were reduced by Pax6 deletion (Fig. 6A) , the responses of individual ␤ Pax6 controls functional ␤ cell identity cells were also altered. Specifically, islet ␤ cells derived from Cre Ϫ animals responded to glucose with a rapid and largely monophasic increase in free cytosolic Ca 2ϩ that was synchronized across the islet (Fig. 7A, top panel, and supplemental movie 3). By contrast, ␤Pax6KO ␤ cells displayed a delayed and oscillatory response, although one that was well coordinated between individual ␤ cells (Fig. 7A, bottom panel, and supplemental Movie 4). Subjecting individual ␤ cell responses to analysis packages that map cell-cell coordination (8, 44, 45) , it was possible to show that the percentage of cells that responded to glucose was unchanged by Pax6 deletion (Fig. 7B ; 77.6 Ϯ 5.39% versus 72.1 Ϯ 4.81% for Cre Ϫ versus Cre ϩ , respectively; ns). However, the level of synchronicity between individual ␤ cells tended to be higher in ␤Pax6KO islets, as shown by an increase in the percentage of significantly correlated cell pairs ( Fig. 7C ; 69.1 Ϯ 7.40% versus 84.7 Ϯ 3.79% for Cre Ϫ versus Cre ϩ , respectively; p ϭ 0.06). Furthermore, the strength of ␤ cell connections was greater in ␤Pax6KO islets, as shown by weighted graphs depicting the location and strength of connections between individual cells (Fig. 7 , D and E; 0.42 Ϯ 0.09 R versus 0.65 Ϯ 0.04 R for Cre Ϫ versus Cre ϩ , respectively; p Ͻ 0.05). These changes were not associated with any alterations in the level of expression of the gap junction protein connexin 36, encoded by Gjd2, an important mediator of cell-cell interactions in the islet (7) (Fig. 3I ).
Discussion
This study sought to determine whether changes in cellular identity, described previously after Pax6 inactivation in ␤ cells (18, 19) , are accompanied by significant changes in ␤ cell function as well as the expression of key ␤ cell genes involved in normal glucose sensing and insulin release. We also sought to determine the importance of Pax6 in maintaining intercellular communication within the islet, a feature required for normal secretory responses to secretagogues that becomes defective in type 2 diabetes (21) .
The use here of the efficient and selective Pdx1CreERT driver line (23, 24, 31) led to the more rapid (within days of tamoxifen treatment) and severe (Ͼ50 mM) hyperglycemia than observed previously after Pax6 deletion either globally (18) or in ␤ cells using the more promiscuous rat insulin promoter 2 (RIP2) Cre driver (19) . Although limited recombination in the brain (chiefly in the basomedial hypothalamus) is also observed with Pdx1CreERT (22) , deletion at extrapancreatic sites (19, 22, 46) or in islet non-␤ cells may contribute to the milder phenotypes observed previously with earlier Cres. Although recombination with Pdx1CreERT has been reported previously to be almost completely confined to ␤ cells (24), we Pax6 controls functional ␤ cell identity did detect a small degree of deletion of PAX6 in ␣ cells. This difference with respect to earlier findings may reflect the differing susceptibility to Cre action of LoxP sites at different genomic locations (47) . Of note, glucagon mRNA levels were not different between WT and KO mice ( Fig. 3J and supplemental Fig. S1D ). On the other hand, we observed a substantial increase in ghrelin expression ( Fig. 3K and supplemental Fig.  S3D) after Pax6 deletion, which may reflect a cell fate switch of ␤ (or possibly ␣) cells toward an ⑀ cell phenotype, as proposed previously (19) .
We consequently chose to study islets from ␤Pax6KO mice at relatively early time points after deletion to minimize the exposure in vivo to high glucose concentrations. This was thought to be important given earlier (48) and more recent (49) reports that hyperglycemia itself leads to a loss of ␤ cell identity. Although at the time point post-tamoxifen used in this study (8 Pax6 controls functional ␤ cell identity days) a significant increase in fasting blood glucose was apparent ( Fig. 2) , the alterations in insulin and glucagon expression observed after Pax6 deletion were markedly different in both extent (insulin) and direction (glucagon) from those reported previously in response to hyperglycemia induced by K ATP channel activation in ␤ cells (49) . Moreover, in this study, islets were cultured at near normal (11 mM) glucose for 24 -48 h after extraction, a maneuver expected to at least partially reverse any changes resulting from antecedent in vivo hyperglycemia. Finally, we observed no (qRT-PCR, Fig. 3H ) or small (RNAseq, supplemental Fig. S1B ) increases in Ldha expression, previ-ously found to be reversibly up-regulated in vivo in islets by hyperglycemia (48) . Thus, we conclude that the alterations in gene expression and function observed in this study are, at least in large part, a reflection of cell-autonomous actions of Pax6 rather than hyperglycemia per se. Notably, the expression of several key ␤ cell genes was affected by Pax6 ablation, with substantial decreases in Ins2, Slc30a8 (ZnT8), MafA, Slc2a2 (Glut2), and Glp1r mRNA levels (Fig. 3) . Although future work will be required to determine whether this reflects direct or indirect regulation of these genes by PAX6, we note that Gck gene expression was increased (Fig. 3F) , demonstrating a degree of selectivity in the regulation of ␤ cell-enriched genes by PAX6.
Interestingly, we also demonstrate that, after Pax6 inactivation, a significant increase occurs in the expression of members of the ␤ cell disallowed gene family, notably Slc16a1/MCT-1 (27) . As far as we are aware, this is the first time that Pax6 has been shown to regulate members of this group. Thus, PAX6 controls ␤ cell identity both through driving the expression of essential glucose-sensing genes and by repressing a gene whose presence is deleterious to ␤ cell function (50) . In this respect, the actions of PAX6 resemble those of RFX6, shown recently to be necessary for both normal ␤ cell development (51) and function (34) .
Although, and in agreement with previous studies, total islet insulin content was reduced by Pax6 deletion by ϳ60% (Fig.  2F) , we were unable to detect any insulin secretion from Pax6null islets in response to glucose. Interestingly, and although explored in a relatively small number of animals (n ϭ 4/genotype), this was not associated with detectable decreases in overall ␤ or ␣ cell mass or in ␤/␣ cell ratio (Fig. 1, G-I) . Deploying cell resolution imaging approaches, we demonstrate that this is associated with marked impairments in glucose-induced ATP/ ADP increases, likely resulting from lowered Glut2 (Slc2a2) but not Gck expression (which was increased) and, possibly, increases in Slc16a1/MCT-1 levels, thus favoring anaerobic glycolysis. We also noted a substantial decrease in the expression of G6pc2 (Fig. 3N ), likely to potentiate the effects of increased Gck expression and thus to increase net flux from glucose to glucose-6P. Because flux control at the initial stages of glycolysis is achieved chiefly at the glucokinase step (1), the above observations suggest that increased flow through the latter reaction is not met by a proportional increase at later stages of glycolysis or in the oxidation of pyruvate and NADH by mitochondria. Future studies will be needed to explore these possibilities in detail. Of note, increased expression and release of ghrelin and binding to ghrelin receptors, which are enriched in ␦ cells (52) , may also enhance somatostatin secretion to suppress insulin release.
Deletion of Pax6 also drastically changed the profile of glucose-stimulated Ca 2ϩ responses from an initial spike of Ca 2ϩ activity followed by a sustained, oscillatory period (34, 53) to more delayed and burst-like properties reminiscent of those observed in ␣ cells (Fig. 7A) (54) . Interestingly, connectivity between cells was not significantly impaired by the loss of Pax6. Rather, we observed a tendency toward increased connectivity and a significant increase in the strength of connections between cells (correlation coefficient; Fig. 7 , D and E) despite 
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unchanged Gjd2 expression ( Fig. 3I ). Thus, impaired ␤ cell-␤ cell communication/connectivity does not drive altered glucose sensing in Pax6-null ␤ cells. Importantly, our findings demonstrate that full ␤ cell maturity is not a prerequisite for the formation of a functional interconnected network of cells. Indeed, we have recently shown the existence of a small population of immature ␤ cells that express high levels of glucokinase and that dictate islet responses to glucose (55) . Whether and how the activity of these putative "hub" or "pacemaker" cells within the islet is affected by Pax6 deletion will be interesting to establish. Of note, elevated Gck expression, alongside substantially lower Pdx1 and Nkx6.1 expression, in ␤Pax6KO islets is a feature characteristic of previously described islet hub cells (55) . These and other changes, including in ion channel expression (RNAseq; "Results" and data not shown) and glucose sensitivity, may thus contribute to the enhanced Ca 2ϩ dynamics and connectivity observed after Pax6 deletion.
Perhaps surprisingly, the partial defects in metabolic glucose signaling observed above (i.e. ATP/ADP and Ca 2ϩ changes) were associated with an apparently complete loss of glucosestimulated insulin secretion, assessed in vitro. This loss of insulin release was less marked in vivo, possibly reflecting alternative mechanisms for stimulating secretion in the living animal (e.g. actions of circulating amino acids or fatty acids, hormonal and neural inputs into the islet, etc.) (1) . Nevertheless, the results obtained with isolated islets would appear to indicate that PAX6 is also important in the ␤ cell for K ATP channel-and Ca 2ϩ -independent mechanisms of glucose-stimulated insulin secretion (56) . Whether enhanced ␤ cell-␤ cell coupling can, in some settings, also be deleterious for the normal tight regulation of insulin secretion is a possibility that also merits investigation.
While the current study was under revision, a report (57) appeared using a similar approach but an alternative Cre (MIP. CreERT), based on the mouse insulin 1 promoter, to delete Pax6 in adult ␤ cells. Importantly, Swisa et al. (57) also identified, by gene ontology analysis, gene classes that may contribute to the enhanced connectivity observed in this report, including ion channels and Ca 2ϩ channels. As observed here, the phenotype of ␤ Pax6-null mice was remarkably severe and associated with ketosis and marked changes in secretory granule structure observed at the ultrastructural level by electron microscopy. Thus, atypical granules, lacking a classical "halo" around the dense core, were frequently seen in null mouse islets. Importantly, lineage tracing work in the report by Swisa et al. (57) also demonstrated that "reprogrammed" cells, expressing ghrelin, were derived from ␤ cells. Finally, it was shown by ChIP sequencing that PAX6 binds directly to sequences in target genes to affect their repression or activation. Importantly, however, the above study did not explore the regulation of insulin secretion or metabolic glucose signaling in Pax6-deleted ␤ cells, as described in this report.
As discussed above and elsewhere (58) , use of the MIP. CreERT deleter strain may, however, be complicated by the concomitant overexpression of human growth hormone. Reassuringly, the strong similarities between the findings of our own study and those described in Ref. 57 indicate that the changes in each are chiefly attributable to altered Pax6 expression.
Experimental procedures
Generation of ␤Pax6KO mice
All animal procedures were approved by the Home Office according to the Animals (Scientific Procedures) Act 1986 of the United Kingdom (PPL 70/7349).
Mice homozygous for the floxed allele of Pax6 (Pax6 fl/fl ), kindly provided by Prof. David Price (University of Edinburgh) (59) , were crossed to a tamoxifen-regulated deleter strain provided by Dr. Doug Melton (Harvard Medical School) in which Cre recombinase is expressed under the control of the Pdx1 promoter (Pdx1CreERT) (23) . The breeding strategy ensured that 50% of the offspring inherited the Cre transgene (Cre ϩ , ␤Pax6KO; Pdx1CreERT ϩ/Ϫ ::Pax6 fl/fl ), the remainder serving as littermate controls (Cre Ϫ , Pdx1CreERT Ϫ/Ϫ ::Pax6 fl/fl ). Gene deletion was achieved by five intraperitoneal tamoxifen injections (2 mg), administered daily to 8-week-old animals of both genotypes. Pdx1CreERT ϩ/Ϫ mice displayed no evident metabolic abnormalities.
Insulin tolerance tests
Bovine insulin (0.75 units/kg body weight, Sigma) was injected into the abdomen of mice fasted for 5 h. Blood glucose measurements were taken at 0, 15, 30, and 60 min using an automatic glucometer (Accu-Chek).
Plasma glucose and insulin measurements
Fed mice were culled, and blood was collected into EDTAcoated tubes (Sarstedt, Beaumont Leys, UK). Glucose measurements were determined using an automatic glucometer (Accu-Chek). For insulin measurements, plasma was separated by centrifugation at 13,200 rpm for 20 min. 5 l of blood plasma was used to measure insulin levels using an ultrasensitive mouse insulin ELISA kit (CrystalChem). For total islet insulin measurements, five islets were lysed by sonication in acidified ethanol (1.5% HCl (v/v), 75% ethanol (v/v), and 0. 1% Triton X-100 (v/v)). Insulin concentration was determined using a HTRF-based assay kit (CisBio).
qRT-PCR
RNA was extracted from isolated islets using TRIzol reagent (Invitrogen) and reverse-transcribed using a high-capacity reverse transcription kit (Invitrogen). Relative gene expression was assessed using SYBR Green (Invitrogen), and expression of each gene was normalized and expressed as n-fold change in mRNA expression versus Cre Ϫ , calculated using the 2 ⌬⌬Ct method (60) .
Massive parallel sequencing of RNA (RNAseq)
Total RNA was extracted with TRIzol from islets isolated from five knock-out and four control mice. Polyadenylated transcripts were selected during the preparation of paired-end, directional RNAseq libraries. Libraries were sequenced on an Illumina HiSeq 2000 machine. The quality of the sequenced libraries was assessed using fastQC. Reads were mapped to the Grc38m assembly using HiSat2. Annotated transcripts were quantified using featureCounts, and differentially expressed genes were identified with DESeq2. All genes were ranked by -fold change, and the resultant list was used for gene set enrichment analysis. Gene set enrichment analysis (GSEA) was performed essentially as described previously (61) , and we used the Broad Institute GSEA tool for analysis of preranked lists with a custom-constructed gene set combining the disallowed genes identified in Ref. 25, 26 .
RNAseq accession codes
Raw sequence data for RNAseq will be made available via deposition to ArrayExpress.
Immunocytochemistry
Pancreata were extracted and fixed in 10% (v/v) formalin, transferred into a tissue-processing cassette, and embedded in paraffin wax within 24 h of being harvested from the mouse. Pancreatic sections were cut at 5 m onto Superfrost slides. Sections were dewaxed by immersion in Histoclear (Sigma-Aldrich, Dorset, UK) for 20 min before rehydration. Antigen retrieval was performed by boiling slides in citrate buffer (Vector Laboratories, Peterborough, UK), washed before blocking with 3% (v/v) goat/donkey serum (Dako, Cambridgshire, UK) in 2% BSA with 0.1% (v/v) Triton X-100 for 1 h at room temperature. Slides were then washed before staining with primary antibody (guinea pig anti-insulin (1:200, Dako), mouse antiglucagon (1:1000, Sigma-Aldrich), and rabbit anti-chromagranin A (1:200, Abcam). Slides were incubated in primary antibody overnight at 4°C. Revelation was performed using a combination of the following secondary antibodies: donkey anti-rabbit 488, goat anti-guinea pig 643, and goat antimouse 568 (all 1:500, Invitrogen). Slides were mounted using Vectashield mounting medium containing DAPI (Vector Laboratories), and a 24-mm coverslip was placed over the slice. Slides were visualized by fluorescence microscopy using a Zeiss Axio Observer inverted wide-field microscope with LED illumination running Zen acquisition software. Quantification of the immunopositive area was achieved using ImageJ analysis software using a macro established in-house. For quantification of ␤ and ␣ cell mass, slides were visualized using an Axiovert 200 M microscope (Zeiss) with Alexa Fluor 488 goat antiguinea pig IgG and Alexa Fluor 568 goat anti-mouse IgG (Invitrogen) using an Axiovert 200 M microscope (Zeiss, Welwyn Garden City, UK) at the Facility for Imaging by Light Microscopy (Imperial College London).
To stain PAX6, an alternative protocol was used based on a modification of the protocol described in Ref. 62 . The main adaptions included permeabilization with methanol (100%, Ϫ20°C, 3 min), more vigorous antigen retrieval via boiling in citrate-based antigen unmasking solution (Vector Laboratories, 15 min), enhanced blocking with 1% (w/v) skimmed milk (1.5 h), and incubation with anti-glucagon antibody (1:500) alone for 2.5 h before overnight incubation with the remaining two primary antibodies (anti-PAX6, Biolegend, 1:70 and antiinsulin, 1:200) and a longer incubation with secondary antibody (2 h). Image acquisition was performed with a Zeiss Axio Observer inverted microscope fitted a Hamamatsu Flash4 cam-era. The filters used were as follows: blue (365-nm LED; excitation, 377/50; emission, 477/60), green (470-nm LED; excitation, 472/30; emission, 520/35), red (540-to 580-nm LED; excitation, 534/20; emission, 572/28), and far red (625-nm LED; excitation, 631/22; emission, 688/20). Negative controls to assess nonspecific binding were performed by omitting incubation with primary antibodies.
Western blotting
Whole-islet extracts were separated using a 10% acrylamide gel and blotted onto a polyvinylidene difluoride membrane. Following blocking for 60 min with 5% (w/v) skimmed milk in TBST (10 mM Tris base (pH 7.6), 150 mM NaCl, and 0.1% Tween 20), membranes were incubated overnight at 4°C with an antibody against Pax6 (1:300, Biolegend). The membrane was washed three times (5 min each) with TBST before incubation of the secondary anti-rabbit HRP antibody (1:5000) for 1 h. An ECL system (GE Healthcare) was used for activation according to the guidelines of the manufacturer. The film was then exposed for 3 s and developed on a Xograph Compact X5 film processor. The membrane was then stripped for incubation with rabbit anti-tubulin (1:5000) as a loading control and re-exposed as above (5 s).
Ca 2؉ imaging and connectivity analysis
Isolated islets were incubated (37°C, 95% O 2 , 5% CO 2 ) for 1 h in Fluo-2/AM (10 M; Teflabs, Austin, TX) diluted in a HEPESbicarbonate buffer solution (120 mM NaCl, 4.8 mM KCl, 1.25 mM NaH 2 PO 4 , 24 mM NaHCO 3 , 2.5 mM CaCl 2 , 1.2 mM MgCl 2 , 10 mM HEPES, and 3 mM D-glucose; all from Sigma). Functional multicellular Ca 2ϩ imaging was achieved using a Nipkow spinning disk head, allowing rapid scanning of islet areas for long periods of time with minimal phototoxicity. A solid-state laser (CrystaLaser) controlled by a laser merge module (Spectral Applied Physics) provided wavelengths of 491 nm to excite Fluo-2 (rate, 0.5 Hz; exposure time, 600 ms). Emitted light was filtered at 525/50 nm, and images were captured with a highly sensitive 16-bit, 512 ϫ 512 pixel back-illuminated EM-CCD camera (ImageEM 9100-13, Hamamatsu). Volocity TM software (PerkinElmer Life Sciences) provided the user interface. During recordings, islets were maintained at 35°C to 36°C and continuously irrigated with bicarbonate buffer aerated with 95% O 2 , 5% CO 2 . Connectivity analysis was performed as described previously (8, 45) .
Measurement of insulin secretion in vitro
Insulin secretion was measured in batch incubations essentially as described previously (63) . In brief, batches of 20 islets from ␤Pax6 KO or control mice were subjected to glucosestimulated insulin secretion assay 1 week after tamoxifen administration (n ϭ 3 animals/genotype). Islets were incubated for 30 min sequentially in 3 mM and then 17 mM glucose. Islets were then lysed in lysis buffer (50 mM TrisCl (pH 8.0), 150 mM NaCl, 1% v/v IGEPAL-C130 (Sigma-Aldrich)), and nuclei were pelleted. The insulin content of secreted and total fractions was determined by HTRF assay and normalized to the DNA content of the nuclear fraction, assayed using CyQuant fluorescent dye.
ATP/ADP imaging
Islets were infected with an adenovirus containing cDNA encoding the ATP sensor Perceval (41) for 48 h to measure intracellular ATP dynamics. Excitation of the fluorescent probe was achieved using a 491-nm laser (Spectral Applied Physics; rate, 0.2 Hz; exposure time, 600 ms). Emitted light was filtered at 525/50 nm, and images were captured as for Ca 2ϩ imaging.
Total internal reflectance of fluorescence (TIRF) analysis
Islets were infected with an adenovirus encoding neuropeptide Y-venus as described previously (64) . Islets were dissociated as described previously (65) , and the liberated cells were allowed to adhere to poly-L-lysine-treated sterile glass slides for 24 h post-transfection. Cells were then incubated for 1 h in HEPES bicarbonate buffer (see Ca 2ϩ imaging analysis) containing 3 mM glucose at 37°C. Fixation was performed by incubating the slides for 1 h at room temperature in PBS supplemented with 4% (v/v) paraformaldehyde.
Imaging was performed as described previously (66) using a Nikon Eclipse Ti microscope equipped with a ϫ100/1.49 numerical aperture (NA) TIRF objective, a TIRF/fluorescence recovery after photobleaching (FRAP) iLas2 module o control laser angle (Roper Scientific), and a Quad Band TIRF filter cube (TRF89902, Chroma). Neuropeptide Y-venus, localized in insulin-secreting vesicles (67) , was excited using a 488-nm laser line, and images were acquired with an ORCA-Flash 4.0 camera (Hamamatsu), and Metamorph software (Molecular Devices) was used for data capture. The laser angle was selected for an imaged section thickness of 150 -180 nm. Images were analyzed on ImageJ using a home-made macro. The script of the macro is available upon request.
Statistical analysis
Statistical significance was assessed using Student's t test. Two-way analysis of variance (with Bonferroni or Sidak multiple comparisons test) was used to examine the effect of multiple variables. Statistical analyses were performed using GraphPad Prism 7.0, ImageJ, and IgorPro. Values represented are the mean Ϯ S.D.
